​

Chemomab Therapeutics Ownership | Who Owns Chemomab Therapeutics?

OverviewFinancialsChart

Chemomab Therapeutics Ownership Summary

Chemomab Therapeutics is owned by 0.04% institutional investors, and 99.96% retail investors.

CMMB Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockChemomab Therapeutics0.04%-99.96%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20231-4,786-57.16%-425.00%--1-
Sep 30, 20231-11,173--986.05%----
Jun 30, 20231-11,173--989.12%----
Mar 31, 20231-11,173--1048.68%----
Dec 31, 20221-11,173--1028.86%----

Recent Insider Transactions

DateNameRoleActivityValue
Jan 03, 2023OrbiMed Israel GP Ltd.-Sell$318.06K
Jan 03, 2023OrbiMed Israel GP Ltd.-Sell$889.70K
Jan 03, 2023Mor George Adi Chief Scientific OfficerSell$38.71K
Jan 03, 2023Mor George Adi Chief Scientific OfficerSell$30.66K
Nov 16, 2022Cohen Neil Harris-Sell$4.82K

Insider Transactions Trends

DateBuySell
2023 Q2--
2023 Q1-4
2022 Q4-3
2022 Q22-
2022 Q16-

CMMB Ownership FAQ

Who Owns Chemomab Therapeutics?

Chemomab Therapeutics shareholders are primarily institutional investors at 0.04%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Chemomab Therapeutics's industry, Biotech Stocks , is 47.04%, which Chemomab Therapeutics falls below.

Does Blackrock own Chemomab Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Chemomab Therapeutics.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools